Delivery Order SPE2DE24DA017-SPE2D625F8HG9
- Not listed
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a $5,775 fixed-price delivery order from the Defense Logistics Agency's Medical Supply Chain on July 23, 2025, for the Arthrex ACP Double Syringe System. This delivery order, with an ultimate completion date of July 28, 2025, represents a task order under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, valued at approximately $471 million...
- Arthrex Inc. was awarded a $4,950 fixed-price delivery order with economic price adjustment by the Defense Logistics Agency's Medical Supply Chain on July 21, 2025, for the Arthrex ACP Double Syringe System, with an ultimate completion date of July 24, 2025. The award represents a non-set-aside contract and is being performed at Arthrex's Naples, Florida location. This delivery order is issued under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics...
- This federal contract award was issued by the Defense Logistics Agency's Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The $4,184.55 Delivery Order contract is for the Arthrex ACP Double Syringe System and has a fixed price with economic price adjustment pricing type. The contract has an ultimate completion date of December 11, 2024. Arthrex Inc. is a for-profit Subchapter S Corporation based in Naples, Florida. The contract is...
- This federal contract award to Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies, is for the delivery of ARTHREX ACP DOUBLE SYRINGE SYSTEM medical devices. The $2,475.00 fixed-price with economic price adjustment contract is a delivery order awarded by the Defense Logistics Agency's Medical Supply Chain, a civilian defense agency. The contract has an ultimate completion date of July 3, 2025 and was awarded on June 30, 2025. Arthrex, a for-profit Subchapter S...
- Arthrex Inc., a leading orthopedic medical device manufacturer headquartered in Naples, Florida, was awarded a delivery order valued at $3,714.60 by the Defense Logistics Agency's Medical Supply Chain on July 21, 2025. The contract, designated as a fixed-price delivery order with economic price adjustment provisions, calls for delivery of an ACP Kit Series I by July 24, 2025, with performance occurring at Arthrex's Naples, Florida location. This award represents a direct competitive...
- Arthrex Inc., a Naples, Florida-based orthopedic medical technology company, received a $28,333.10 fixed-price delivery order from the Defense Logistics Agency's Medical Supply Chain on July 21, 2025, with completion expected by July 24, 2025. This delivery order was awarded without set-aside restrictions, reflecting Arthrex's competitive standing in the federal marketplace. The contract represents a task order issued under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the...
- Arthrex Inc., headquartered in Naples, Florida, received a delivery order award valued at $2,889.00 for an ACP Kit Series I from the Defense Logistics Agency's Medical Supply Chain on July 24, 2025. This fixed-price delivery order with economic price adjustment provisions is set to be completed by July 29, 2025. The award represents a task order issued under Arthrex's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (SPE2DE24D0020), valued at approximately $471 million...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a delivery order award (Contract No. 4568897823, FLIPCUTTER III) valued at $10,985.72 from the Defense Logistics Agency's Medical Supply Chain on July 25, 2025. This fixed-price delivery order with economic price adjustment provisions is set to be completed by July 30, 2025, and will be performed at Arthrex's Naples, Florida facility. The delivery order falls under Arthrex's existing...
- This is a $3,577.30 fixed-price delivery order contract awarded by the Defense Logistics Agency's Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies. The contract is for the procurement of the ARTHREX ACP DOUBLE SYRINGE SYSTEM, a specialized medical device used in orthopedic procedures. The contract has an ultimate completion date of March 21, 2025 and does not utilize a set-aside designation. Arthrex Inc. is a for-profit Subchapter S...
- Arthrex Inc., a leading provider of minimally invasive orthopedic medical technologies, was awarded a fixed-price delivery order valued at $3,029.40 by the Defense Logistics Agency's Medical Supply Chain on July 24, 2025, for the ACP MAX PRP System with ACDA. The delivery order, which is not set-aside for any specific business category, has an ultimate completion date of July 29, 2025, and will be performed in Naples, Florida. This award represents a task order under Arthrex's broader Indefinite...
- SPE2DE24DA017Indefinite Delivery Contract
- SPE2DE24DA017-SPE2D625F8HG9Delivery Order
Arthrex Inc., a leading global orthopedic medical device manufacturer headquartered in Naples, Florida, was awarded a $8,664.00 fixed-price delivery order for the ARTHREX ACP Double Syringe System by the Defense Logistics Agency's Medical Supply Chain on July 23, 2025. The delivery order, which carries an ultimate completion date of July 28, 2025, represents a task order against Arthrex's existing Indefinite Delivery Contract (SPE2DE24D0020) valued at $471,048,172.66 and running through September 1, 2029. The contract utilizes fixed-price pricing with economic price adjustment provisions and carries no set-aside designation, reflecting Arthrex's strong competitive position in the federal marketplace for orthopedic technologies. As a Subchapter S Corporation and established supplier to the Department of Veterans Affairs and Department of Defense, Arthrex supplies advanced orthopedic medical devices, surgical implants, arthroscopic instruments, and biologics to government healthcare systems. The ACP Double Syringe System represents one component of the company's comprehensive orthopedic product portfolio delivered through its comprehensive IDC with the Defense Logistics Agency, which has generated over $550,000 in delivery orders to date. Performance is scheduled to take place at the company's Naples, Florida facility, enabling efficient fulfillment to support the orthopedic surgical requirements of veterans and military personnel across the nation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.7k | 7/23/25 |